In a seven-day mouse comparison, T0901317 increased hepatic triglycerides in wild-type mice, whereas LXRα/β-null mice showed no significant hepatic increase. In a separate four-week study, 1 mg/kg daily lowered plasma triglycerides in chow-fed male C57BL/6 mice while increasing hepatic triglycerides. Plasma responses should be interpreted within each tested regimen and model. [1,3]
LXR-dependent hepatic and plasma lipid effects
Animal study · Wild-type and LXRα/β−/− mice; four groups, n=5 per group [1]
At seven days, the hepatic triglyceride and lipogenic gene responses seen in wild-type mice were markedly attenuated in LXR-null mice. Baseline lipid levels also differed by genotype.
Conditions shared by the study groups
- Treatment course
- 7 d
- Wild-type mice receiving T0901317
- Model: Wild-type mice; n=5 per treatment/control group
- Reported limits: Dose is on Fig. 5C–D. Route, frequency, vehicle composition, sex and age are not specified for this genotype experiment in the retrieved description.
- LXRα/β-null mice receiving T0901317
- Model: LXRα/β−/− mice; n=5 per treatment/control group
- Reported limits: Do not import the 5 mg/kg regimen from the separate GEM microarray experiment.
Methods and source locations
Compound reported in the paper: T0901317
Evidence concerns the reported experimental material; it does not validate an Adooq lot.
Results, paragraph preceding Fig. 5; Fig. 5A–D and caption; Materials and methods, Plasma lipid analysis
Hepatic triglycerides in wild-type mice relative to vehicle: Hepatic lipid extraction and triglyceride analysis; Fig. 5C — Results, paragraph preceding Fig. 5; Fig. 5A–D and caption; Materials and methods, Plasma lipid analysis
Hepatic triglyceride response in LXRα/β−/− mice: Fig. 5C and accompanying Results — Results, paragraph preceding Fig. 5; Fig. 5A–D and caption; Materials and methods, Plasma lipid analysis
Wild-type mice receiving T0901317 · Results, paragraph preceding Fig. 5; Fig. 5A–D and caption; Materials and methods, Plasma lipid analysis
LXRα/β-null mice receiving T0901317 · Results, paragraph preceding Fig. 5; Fig. 5A–D and caption; Materials and methods, Plasma lipid analysis
Four-week lipid response in wild-type mice
Animal study · Male C57BL/6 mice, standard chow; treatment started at 8–10 weeks [3]
Longer treatment lowered circulating triglycerides while increasing liver triglycerides. Plasma IDL/LDL triglycerides and hepatic SREBP-1c/PLTP mRNA were not significantly changed.
Conditions shared by the study groups
- Route
- Oral gavage
- Frequency
- Daily
- Treatment course
- 4 weeks
- Vehicle
- 20% microemulsion
- T0901317 in chow-fed male C57BL/6 mice
- Model: Male C57BL/6 mice, standard chow; treatment/control n=9 each for plasma and hepatic triglycerides
- Reported limits: Vehicle components are referenced elsewhere but not detailed here; no composition reconstructed.
Methods and source locations
Compound reported in the paper: T0901317
Evidence concerns the reported experimental material; it does not validate an Adooq lot.
Methods 2.1, 2.2 and 2.7; Results 3.1; Fig. 1A–B,E–F and caption
Plasma total triglycerides versus vehicle: Commercial enzymatic lipid kits; FPLC for lipoprotein fractions — Methods 2.1, 2.2 and 2.7; Results 3.1; Fig. 1A–B,E–F and caption
Hepatic triglycerides versus vehicle: Liver lipid extraction and enzymatic assay; Fig. 1F — Methods 2.1, 2.2 and 2.7; Results 3.1; Fig. 1A–B,E–F and caption
T0901317 in chow-fed male C57BL/6 mice · Methods 2.1, 2.2 and 2.7; Results 3.1; Fig. 1A–B,E–F and caption